The Food and Drug Administration is facing backlash over its approval of a genetic test intended to determine if a person is at increased risk for opioid addiction.
Related Posts
Kiribati and Samoa implement rare lockdowns after travelers test positive
- UNR Newswire
- June 13, 2022
- 0
Dozens of travelers from Fiji tested positive
Texas doctor accused of manipulating transplant lists
- blkalertshealth
- April 13, 2024
- 0
Liver transplants have been halted at a Houston ho
Study finds a new type of bacteria present in colorectal cancer
- blkalertshealth
- March 22, 2024
- 0
According to a study in the scientific journal Nat